Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06805994 · ClinicalTrials.gov registry record · Phase 1
Administering NMT to Reestablish Infant Nasal Microbiome Diversity Following Intranasal Mupirocin Treatment
A Phase 1 study of Microbial Colonization and Staphylococcal Aureus Infection, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 175
- Enrollment target
- 1
- Study location
NCT06805994: Recruiting Phase 1 study of Microbial Colonization and Staphylococcal Aureus Infection, sponsored by Johns Hopkins University.
NCT06805994 is a Phase 1 study of Microbial Colonization and Staphylococcal Aureus Infection that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 175 participants, below the 12,646-participant average among 20 other Microbial Colonization trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06805994, a Phase 1 study of Microbial Colonization and Staphylococcal Aureus Infection, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 175 participants
- Enrollment target
- 1
- Study location
Study Summary
This protocol aims to evaluate how NMT affects pediatric nasal microbiome diversity following intranasal mupirocin treatment
Primary Outcome
This outcome will be determined by analysis of periodic surveillance swabs collected after intervention.
Conditions Studied
Interventions
- BIOLOGICAL Placebo
- BIOLOGICAL Nasal Microbiota Transplant (NMT)
Study Locations (1)
Maryland
- Johns Hopkins University - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 175 participants |
| Start Date | 2025-08-27 |
| Est. Completion | 2028-01-01 |
| Phase | Phase 1 |
What NCT06805994 shows while recruiting
NCT06805994 is an interventional study that assigns participants to a tested intervention. The registered 175 participants enrollment target is mid-sized for trials with a published cap, below the 12,646-participant average among 20 other Microbial Colonization trials with a reported enrollment target (99% lower).
The record links to 5 conditions, with Microbial Colonization appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06805994 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT06805994 about?
NCT06805994 is a clinical study titled "Administering NMT to Reestablish Infant Nasal Microbiome Diversity Following Intranasal Mupirocin Treatment". This protocol aims to evaluate how NMT affects pediatric nasal microbiome diversity following intranasal mupirocin treatment
What is the current status of trial NCT06805994?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 175 participants. The study started on 2025-08-27. Estimated completion is 2028-01-01.
What conditions does trial NCT06805994 study?
This clinical trial studies the following conditions: Microbial Colonization, Staphylococcal Aureus Infection, Pediatric Infection, S. Aureus Colonization, Microbial Transplant.
What interventions are being tested in trial NCT06805994?
The interventions under investigation include: Placebo (BIOLOGICAL), Nasal Microbiota Transplant (NMT) (BIOLOGICAL).
Who is sponsoring clinical trial NCT06805994?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06805994 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Microbial Colonization
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06805994's enrollment target sits among peer trials
175 6th of 20 higher than 14 of 20 other Microbial Colonization trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Microbial Colonization trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Comparing Single Versus Repeat NMT on the Diversity of the Neonatal Nasal Microbiome
RECRUITING · Phase 1
-
Microbiome Derived Metabolism and Pharmacokinetics
RECRUITING · Phase 1
-
Feasibility and Safety Study of Parent-to-Child Nasal Microbiota Transplant
ACTIVE NOT RECRUITING · Phase 1
-
Changes in Microbial Status From Dentate, Edentulous and After Dental Implant Placement
RECRUITING
-
Skin Preparation for Elective Foot and Ankle Surgery
RECRUITING · Phase 4
-
Effects of Mouthrinse on the Microbiome of the Oral Cavity and GI Tract
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04722341 · 175 participants · NA
Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators
- NCT05094037 · 175 participants · NA
Orthotic Treatment of Diabetic Foot Ulcers
- NCT05165745 · 175 participants · NA
Stick2PrEP Cisgender Women and Trans Individuals
- NCT05312255 · 175 participants · NA
Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI